Brookfield Corp’s QuidelOrtho QDEL Stock Holding History

Brookfield Corp’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44,947	Closed	-$3.85M	–	759
2022 Q4	$3.85M	Buy	44,947 +13,110	+41%	+$1.11M	0.01%	305
2022 Q3	$2.28M	Buy	+31,837	New	+$2.85M	0.01%	433
2022 Q2	–	Sell	-3,754	Closed	-$422K	–	726
2022 Q1	$422K	Buy	+3,754	New	+$400K	﹤0.01%	557
2020 Q4	–	Sell	-10,473	Closed	-$2.3M	–	509
2020 Q3	$2.3M	Buy	+10,473	New	+$2.34M	0.01%	223

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Brookfield Corp's QDEL Position: Q1 2023 in Review

Brookfield Corp sold out of QuidelOrtho (QDEL) in Q1 2023, closing a stake of 44,947 shares — an estimated $3.85M sold.

Brookfield Corp first reported a position in QDEL in Q3 2020 and held it in 4 quarters. The position peaked at $3.85M in Q4 2022. 331 funds tracked by Wall St. Rank hold QDEL as of Q1 2023.

Brookfield Corp reported no remaining QuidelOrtho position as of Q1 2023 after selling out during the quarter.
Brookfield Corp sold 44,947 QuidelOrtho shares in Q1 2023, an estimated $3.85M.
Brookfield Corp first reported a position in QuidelOrtho in Q3 2020 and held it in 4 quarters.
Brookfield Corp's QuidelOrtho position peaked at $3.85M in Q4 2022.
331 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.